The team at Aldevron is excited to virtually celebrate our recent expansion in Madison and share the great progress we’re making and opportunities ahead in the world of gene therapy.

Aldevron’s Protein Business Unit manufactures recombinant proteins used in a wide range of applications including research, diagnostics, and therapeutics. Our company as a whole is really focused on the exciting new frontier of genetic medicine and being an end-to-end solutions provider.

What we deliver are products that enable our clients to develop these new genetic therapies, which help patients who in many cases don’t have a drug or treatment for their specific disease or condition that’s been successful – or that doesn’t exist at all.

Read the full article on BioForward’s website.